Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Cmelak

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Head & Neck|July 24, 2009
Reliability and validity of the Vanderbilt Head and Neck Symptom Survey: a tool to assess symptom burden in patients treated with chemoradiationBarbara A Murphy, Mary S Dietrich, Nancy Wells, et al.
American Journal of Otolaryngology|October 15, 2021
Impact of COVID-19 on presentation, staging, and treatment of head and neck mucosal squamous cell carcinomaMadelyn N Stevens, Ankita Patro, Bushra Rahman, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 15, 2020
Contemporary Management of Jugular Paragangliomas With Neural PreservationNauman F Manzoor, Kristen L Yancey, Joseph M Aulino, et al.
Head & Neck|February 12, 2022
Management of postradiation late hemorrhage following treatment for HPV-positive oropharyngeal squamous cell carcinomaMadelyn N Stevens, Jean-Nicolas Gallant, Michael J Feldman, et al.
The Lancet. Oncology|January 19, 2015
Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trialRicard Mesía, Michael Henke, Andre Fortin, et al.
Advances in Radiation Oncology|June 15, 2026
Virtual Patient-Specific 3-Dimensional Specimen Maps for Adjuvant Radiation Therapy Planning in Mucosal Head and Neck Squamous Cell CarcinomaWhitney Jin, Michael C Topf, Marina Aweeda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomasChristine H Chung, Kim Ely, Loris McGavran, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancyAndy Trotti, Adam Garden, Padraig Warde, et al.
The New England Journal of Medicine|October 26, 2007
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancerMarshall R Posner, Diane M Hershock, Cesar R Blajman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2025
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck CancerMitchell Machtay, Pedro A Torres-Saavedra, Wade Thorstad, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Head & Neck|July 24, 2009
Reliability and validity of the Vanderbilt Head and Neck Symptom Survey: a tool to assess symptom burden in patients treated with chemoradiationBarbara A Murphy, Mary S Dietrich, Nancy Wells, et al.
American Journal of Otolaryngology|October 15, 2021
Impact of COVID-19 on presentation, staging, and treatment of head and neck mucosal squamous cell carcinomaMadelyn N Stevens, Ankita Patro, Bushra Rahman, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 15, 2020
Contemporary Management of Jugular Paragangliomas With Neural PreservationNauman F Manzoor, Kristen L Yancey, Joseph M Aulino, et al.
Head & Neck|February 12, 2022
Management of postradiation late hemorrhage following treatment for HPV-positive oropharyngeal squamous cell carcinomaMadelyn N Stevens, Jean-Nicolas Gallant, Michael J Feldman, et al.
The Lancet. Oncology|January 19, 2015
Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trialRicard Mesía, Michael Henke, Andre Fortin, et al.
Advances in Radiation Oncology|June 15, 2026
Virtual Patient-Specific 3-Dimensional Specimen Maps for Adjuvant Radiation Therapy Planning in Mucosal Head and Neck Squamous Cell CarcinomaWhitney Jin, Michael C Topf, Marina Aweeda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomasChristine H Chung, Kim Ely, Loris McGavran, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancyAndy Trotti, Adam Garden, Padraig Warde, et al.
The New England Journal of Medicine|October 26, 2007
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancerMarshall R Posner, Diane M Hershock, Cesar R Blajman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2025
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck CancerMitchell Machtay, Pedro A Torres-Saavedra, Wade Thorstad, et al.
Pageof 3